Takeda, Immusoft Partnered to Develop Cell Therapies for Rare Neurometabolic Disorder

Immusoft, a cell therapy company, which has been dedicated to improve the lives of the patients with rare diseases and Takeda Pharmaceutical Company Limited has partnered for the purpose of developing and commercializing the transformative cell therapies in the rare inherited metabolic disorders along with the central nervous system manifestations and the complications that has […]

Continue Reading